TrustCore Financial Services’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$192K Hold
2,090
– – 0.02% 276
2022
Q3
$252K Hold
2,090
– – 0.02% 236
2022
Q2
$161K Hold
2,090
– – 0.02% 280
2022
Q1
$325K Buy
2,090
+675
+48% +$114K 0.03% 218
2021
Q4
$341K Hold
1,415
– – 0.04% 197
2021
Q3
$608K Hold
1,415
– – 0.06% 151
2021
Q2
$773K Hold
1,415
– – 0.08% 127
2021
Q1
$553K Hold
1,415
– – 0.06% 156
2020
Q4
$606K Hold
1,415
– – 0.08% 136
2020
Q3
$1.2M Hold
1,415
– – 0.18% 69
2020
Q2
$1.17M Hold
1,415
– – 0.2% 67
2020
Q1
$525K Hold
1,415
– – 0.12% 111
2019
Q4
$539K Buy
1,415
+1,394
+6,638% +$911K 0.1% 126
2019
Q3
$36K Hold
21
– – 0.01% 425
2019
Q2
$34K Buy
+21
New +$41.6K 0.01% 425

Other funds holding KRSA

TrustCore Financial Services's KRSA Position: Q4 2022 in Review

TrustCore Financial Services held its Korsana Biosciences (KRSA) position steady in Q4 2022 at 2,090 shares worth $192K. The position accounts for 0.02% of the portfolio, ranked #276.

TrustCore Financial Services first reported a position in KRSA in Q2 2019 and has held it in 15 quarters since. The position peaked at $1.2M in Q3 2020. 33 funds tracked by Wall St. Rank hold KRSA as of Q4 2022.

  • TrustCore Financial Services held 2,090 shares of Korsana Biosciences worth $192K as of Q4 2022.
  • TrustCore Financial Services left its Korsana Biosciences share count unchanged in Q4 2022.
  • Korsana Biosciences made up 0.02% of TrustCore Financial Services's portfolio in Q4 2022, its #276 holding.
  • TrustCore Financial Services first reported a position in Korsana Biosciences in Q2 2019 and has held it in 15 quarters since.
  • TrustCore Financial Services's Korsana Biosciences position peaked at $1.2M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Korsana Biosciences as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.